Reilly JT - Search Results

1

Class III receptor tyrosine kinases: role in leukaemogenesis.

Reilly JT. Reilly JT. Br J Haematol. 2002 Mar;116(4):744-57. doi: 10.1046/j.0007-1048.2001.03294.x. Br J Haematol. 2002. PMID: 11886377 Review. No abstract available.

2

c-FMS mutational analysis in acute myeloid leukaemia.

Abu-Duhier FM, Goodeve AC, Wilson GA, Peake IR, Reilly JT. Abu-Duhier FM, et al. Among authors: reilly jt. Br J Haematol. 2003 Nov;123(4):749-50. doi: 10.1046/j.1365-2141.2003.04681.x. Br J Haematol. 2003. PMID: 14616987 No abstract available.

3

Neutrophil inclusions in cryoglobulinaemia.

Laidlaw ST, Wagner B, Reilly JT. Laidlaw ST, et al. Among authors: reilly jt. Br J Haematol. 2003 Aug;122(3):344. doi: 10.1046/j.1365-2141.2003.04471.x. Br J Haematol. 2003. PMID: 12877661 No abstract available.

4

Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?

Reilly JT. Reilly JT. Br J Haematol. 2005 Jan;128(1):18-34. doi: 10.1111/j.1365-2141.2004.05236.x. Br J Haematol. 2005. PMID: 15606546 Review.

5

Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis.

McMullin MF, Reilly JT, Campbell P, Bareford D, Green AR, Harrison CN, Conneally E; National Cancer Research Institute, Myeloproliferative Disorder Subgroup, Ryan K; British Committee for Standards in Haematology. McMullin MF, et al. Among authors: reilly jt. Br J Haematol. 2007 Sep;138(6):821-2. doi: 10.1111/j.1365-2141.2007.06741.x. Epub 2007 Aug 2. Br J Haematol. 2007. PMID: 17672880 No abstract available.

6

Acute myeloid leukaemia with associated eosinophilia: justification for FIP1L1-PDGFRA screening in cases lacking the CBFB-MYH11 fusion gene.

Sorour Y, Dalley CD, Snowden JA, Cross NC, Reilly JT. Sorour Y, et al. Among authors: reilly jt. Br J Haematol. 2009 Jul;146(2):225-7. doi: 10.1111/j.1365-2141.2009.07746.x. Epub 2009 May 19. Br J Haematol. 2009. PMID: 19466970 No abstract available.

7

Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.

Reilly JT, McMullin MF, Beer PA, Butt N, Conneally E, Duncombe AS, Green AR, Mikhaeel G, Gilleece MH, Knapper S, Mead AJ, Mesa RA, Sekhar M, Harrison CN. Reilly JT, et al. Br J Haematol. 2014 Nov;167(3):418-20. doi: 10.1111/bjh.12985. Epub 2014 Jun 25. Br J Haematol. 2014. PMID: 24961987 Free article. No abstract available.

8

Guideline for the diagnosis and management of myelofibrosis.

Reilly JT, McMullin MF, Beer PA, Butt N, Conneally E, Duncombe A, Green AR, Michaeel NG, Gilleece MH, Hall GW, Knapper S, Mead A, Mesa RA, Sekhar M, Wilkins B, Harrison CN; Writing group: British Committee for Standards in Haematology. Reilly JT, et al. Br J Haematol. 2012 Aug;158(4):453-71. doi: 10.1111/j.1365-2141.2012.09179.x. Epub 2012 Jun 1. Br J Haematol. 2012. PMID: 22651893

9

Practical approach to treating essential thrombocythaemia: case studies.

Reilly JT. Reilly JT. Eur J Haematol Suppl. 2007 Oct;(68):40-2. doi: 10.1111/j.1600-0609.2007.00944.x. Eur J Haematol Suppl. 2007. PMID: 17727566 No abstract available.

10

Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice.

Reilly JT. Reilly JT. Eur J Haematol Suppl. 2007 Oct;(68):32-4. doi: 10.1111/j.1600-0609.2007.00942.x. Eur J Haematol Suppl. 2007. PMID: 17727564 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results